Limited Rollout Planned For Fibrocell's Newly Approved Aesthetic Cellular Therapy
This article was originally published in The Pink Sheet Daily
Executive Summary
The initial indication for laViv is treatment of nasolabial fold wrinkles, but Fibrocell is eyeing additional indications for its autologous cell therapy.